A double‐blind placebo‐controlled pilot study of immunoglobulin for small fiber neuropathy associated with TS‐HDS and FGFR‐3 autoantibodies CH Gibbons, S Rajan, K Senechal, E Hendry, B McCallister, TD Levine Muscle & Nerve 67 (5), 363-370, 2023 | 17 | 2023 |
Validity of Mental and Physical Stress Models E Hendry, B McCallister, DJ Elman, R Freeman, D Borsook, I Elman Neuroscience & Biobehavioral Reviews, 105566, 2024 | 2 | 2024 |
A double-blind, placebo controlled trial of Gamunex-C in patient with small fiber neuropathy associated with autoantibodies to TS-HDS and FGFR3 (P8-13.002) C Gibbons, S Rajan, K Senechal, E Hendry, B McCallister, T Levine Neurology 98 (18 Supplement), 2022 | 1 | 2022 |
Conceptual framework for preterm birth review in San Francisco JD Stookey, S Guendelman, B McCallister, P Whittemore, D Abu-Amara, ... Frontiers in Public Health 12, 1332972, 2024 | | 2024 |
Reply to “Intravenous saline may not be a placebo in patients with small fiber neuropathy” CH Gibbons, S Rajan, K Senechal, E Hendry, B McCallister, TD Levine Muscle & Nerve 67 (6), E26-E27, 2023 | | 2023 |
A DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF IVIG IN PATIENT WITH SMALL FIBER NEUROPATHY ASSOCIATED WITH AUTOANTIBODIES TO TS-HDS AND FGFR3 C Gibbons, S Rajan, K Senechal, E Hendry, B McCallister, T Levine JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 27, S151-S152, 2022 | | 2022 |
FLASH Radiotherapy: Skin Pigmentation as a Non-Invasive Indicator for Radiation-Induced Damage B McCallister | | 2021 |